• Explore /
  • Poster
  • / Treatment-free survival after first-line therapies for metastatic renal cell carcinoma: An International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) analysis.

Treatment-free survival after first-line therapies for metastatic renal cell carcinoma: An International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) analysis.

Abstract Poster

Authors

null

Mehul Gupta

Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada

Mehul Gupta , Connor Wells , Meredith M. Regan , Wanling Xie , Vishal Navani , Renee Maria Saliby , Naveen S. Basappa , Frede Donskov , Takeshi Yuasa , Kosuke null Takemura , Christian K. Kollmannsberger , Megan Crumbaker , Aly-Khan A. Lalani , Thomas Powles , Sumanta Kumar Pal , Rana R. McKay , Jae-Lyun Lee , Ravindran Kanesvaran , Toni K. Choueiri , Daniel Yick Chin Heng

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer

Sub Track

Quality of Care/Quality Improvement and Real-World Evidence

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 390)

DOI

10.1200/JCO.2024.42.4_suppl.390

Abstract #

390

Poster Bd #

F14

Abstract Disclosures

Similar Posters

First Author: Neil J. Shah

First Author: Chun Loo Gan

First Author: Daniel M. Geynisman

First Author: Audreylie Lemelin